News Room
EVT: Earn Needed Income With This High-Yielding CEF (NYSE:EVT)
There can be little doubt that one of the biggest problems affecting the average American today is the rapidly rising…
US regulators approve first drug to slow progression of Alzheimer’s
Receive free Dementia updatesWe’ll send you a myFT Daily Digest email rounding up the latest Dementia news every morning. The…
Tesla data sparks rotation to EVs from AI as stock-market investors chase rally
Individual investors keep chasing a 2023 stock-market rally, but are showing signs of pivoting toward electric-vehicle makers and away from…
Amazon, Best Buy, Walmart and Target set for consumer turnaround, says Placer.ai
Major retailers are preparing their big July sales events, with Amazon.com Inc.’s Prime Day, Best Buy Co.’s Black Friday in…
Amazon’s iRobot deal in EU antitrust crosshairs
© Reuters. FILE PHOTO: An Amazon logo is pictured at a logistics centre in Mannheim, Germany, September 17, 2019. REUTERS/Ralph…
Goldman says West needs over $25 billion investments in rare earths to match China
(Reuters) - Goldman Sachs (NYSE:) on Thursday said the West may need more than $25 billion in investments to match…
David Einhorn Builds Up Green Brick Partners Stake
Summary The position was increased by 4.98%. The company recently reported a record quarter. After reducing his stake in Green…
FDA Has Approved The Anti-Alzheimer’s Drug Leqembi. What You Need To Know
The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers…